TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14660265

Group type: EXPERIMENTAL
Intervention: 1.5% ciclopirox olamine shampoo
Number of subjects: 64

Group type: COMPARATOR
Intervention: 2% ketoconazole shampoo
Number of subjects: 64
Study: 11528495

Group type: EXPERIMENTAL
Intervention: Fruit juice (1 l per day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fruit-vegetable-concentrate (30 ml per day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (HIV-seronegative subjects)
Number of subjects: 41
Study: 9371896

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Zolmitriptan doses > or = 2.5 mg
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Zolmitriptan (second dose)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Zolmitriptan doses < or = 2.5 mg
Number of subjects: 999

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 999
Study: 1553930

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4.2 g of omega-3 fatty acids per day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3993553

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30141340

Group type: EXPERIMENTAL
Intervention: Eczema Action Plan (EAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 0
Study: 27982166

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 18
Study: 25242558

Group type: EXPERIMENTAL
Intervention: Ixekizumab 120 mg subcutaneous every 4 weeks during OLE
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ixekizumab (previously randomized, placebo-controlled trial)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ixekizumab during OLE
Number of subjects: 120
Study: 22287580

Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 51
Study: 20075184

Group type: EXPERIMENTAL
Intervention: Sodium valproate (500 mg, intravenous)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Haloperidol (10 mg, intramuscular)
Number of subjects: 30
Study: 18774469

Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer
Number of subjects: 267994

Group type: EXPERIMENTAL
Intervention: Active observation
Number of subjects: 267994

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267994
Study: 15692541

Group type: EXPERIMENTAL
Intervention: Coblation-assisted intracapsular tonsillectomy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Electrocautery tonsillectomy
Number of subjects: 101
Study: 12593521

Group type: COMPARATOR
Intervention: BDP via metered-dose inhaler (MDI) 1,600 microg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BDP suspension for nebulization 1,600 microg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BDP suspension for nebulization 3,200 microg
Number of subjects: 12
Study: 12165579

Group type: EXPERIMENTAL
Intervention: Single remote course of antenatal corticosteroids (two 12‐mg doses of betamethasone)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Weekly courses of antenatal corticosteroids
Number of subjects: 37
Study: 10660867

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg.kg-1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7789043

Group type: EXPERIMENTAL
Intervention: Clonidine (infusion rates of 16-2048 ng/min)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (non-diabetic subjects)
Number of subjects: 44
Study: 2314446

Group type: EXPERIMENTAL
Intervention: Proton nuclear magnetic resonance (NMR) spectroscopy in plasma samples from patients with cancer
Number of subjects: 268

Group type: COMPARATOR
Intervention: Proton nuclear magnetic resonance (NMR) spectroscopy in plasma samples from healthy controls
Number of subjects: 268

Group type: COMPARATOR
Intervention: Proton NMR spectroscopy in male controls 40 years old or older
Number of subjects: 268

Group type: COMPARATOR
Intervention: Proton NMR spectroscopy in female controls 40 years old or older
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Proton NMR spectroscopy in women with cancer
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Proton NMR spectroscopy in men with cancer
Number of subjects: 268
Study: 6107587

Group type: EXPERIMENTAL
Intervention: Intravenous and oral disopyramide
Number of subjects: 199

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 199
Study: 6652010

Group type: COMPARATOR
Intervention: Morphine 10 mg i.m.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Morphine 5 mg into the extradural space
Number of subjects: 30
Study: 31663833

Group type: EXPERIMENTAL
Intervention: Titanium mesh cages (TMC)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Autogenous iliac bone grafts (AIBG)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both groups (TMC and AIBG)
Number of subjects: 146
Study: 31053510

Group type: EXPERIMENTAL
Intervention: Vegetable first, followed by meat and rice (V-M-R)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Meat first, followed by vegetable and rice (M-VR)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vegetable, meat and rice consumed together (VMR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Rice consumed first followed by vegetable and meat (R-VM)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vegetable first followed by meat and rice (V-M-R)
Number of subjects: 16
Study: 29774465

Group type: EXPERIMENTAL
Intervention: 4000 mg myo-inositol plus 400 mcg folic acid (MI treatment)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 500 mg D-chiro-inositol plus 400 mcg folic acid (DCI treatment)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1100/27.6 mg myo/D-chiro-inositol plus 400 mcg folic acid (MI plus DCI treatment)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 400 mcg folic acid (control treatment)
Number of subjects: 80
Study: 27760402

Group type: EXPERIMENTAL
Intervention: CC-60 (21 mg/day carotenes)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: TRF-80 (420 mg/day tocotrienol + 132 mg/day tocopherol)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (palm olein)
Number of subjects: 90
Study: 24923573

Group type: EXPERIMENTAL
Intervention: Filiform needles (acupuncture)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Thumbtack intradermal (TI) needles (control)
Number of subjects: 58
Study: 22836707

Group type: EXPERIMENTAL
Intervention: Tai Chi (50 min daily training for 6 months)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study: 20555293

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel
Number of subjects: 694

Group type: COMPARATOR
Intervention: Aqueous chlorhexidine
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Household-level acceptability study
Number of subjects: 694
Study: 18453389

Group type: EXPERIMENTAL
Intervention: Mortality-related health-risk information about driving
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Prime to behave responsibly alongside mortality-related information
Number of subjects: 339
Study: 16168152

Group type: EXPERIMENTAL
Intervention: COPE
Number of subjects: 91

Group type: COMPARATOR
Intervention: No‐COPE
Number of subjects: 91
Study: 12673150

Group type: EXPERIMENTAL
Intervention: Resistance training (BR-Tr group: N = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nontraining (BR-Cont group: N = 6)
Number of subjects: 12
Study: 10727068

Group type: EXPERIMENTAL
Intervention: IR120 (7 bouts of 120 s runs with 120 s rest)
Number of subjects: 10

Group type: COMPARATOR
Intervention: IR60 (14 bouts of 60 s runs with 60 s rest)
Number of subjects: 10
Study: 8789545

Group type: EXPERIMENTAL
Intervention: Cetirizine (30 mg daily for 5 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg daily for 5 days)
Number of subjects: 12
Study: 1615546

Group type: EXPERIMENTAL
Intervention: Intravenous glycerol (500 ml of 10% glycerol in saline by intravenous infusion over 4 hours on 6 consecutive days)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Saline treatment (placebo)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Intravenous glycerol
Number of subjects: 216
Study: 6495087

Group type: EXPERIMENTAL
Intervention: Intramuscular atropine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Intramuscular glycopyrrolate
Number of subjects: 25
Study: 31143882

Group type: EXPERIMENTAL
Intervention: CC‐Cruiser
Number of subjects: 350

Group type: COMPARATOR
Intervention: Senior consultants
Number of subjects: 350
Study: 30241687

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg BID for 6 times
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Thioctic acid 600 mg once daily for 3 times
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination of pregabalin and thioctic acid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 42
Study: 26969528

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) combined with effortful swallowing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo group (NMES with electrical sensation)
Number of subjects: 50
Study: 24708735

Group type: EXPERIMENTAL
Intervention: Oral dose of 50,000 IU vitamin A
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 22488716

Group type: EXPERIMENTAL
Intervention: Microwave ablation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Partial nephrectomy
Number of subjects: 102
Study: 20081227

Group type: EXPERIMENTAL
Intervention: Triple therapy (cilostazol, thienopyridine, aspirin)
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Dual therapy (thienopyridine, aspirin)
Number of subjects: 1597

Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Triple therapy and Dual therapy
Number of subjects: 1597
Study: 19097974

Group type: EXPERIMENTAL
Intervention: BB condition (bulletin board)
Number of subjects: 1375

Group type: COMPARATOR
Intervention: UC condition (usual care)
Number of subjects: 1375

Group type: EXPERIMENTAL
Intervention: Participants who attempted to quit within a few days of study entry
Number of subjects: 1375
Study: 15829326

Group type: EXPERIMENTAL
Intervention: EP (etoposide and cisplatin)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: CEV (cyclophosphamide, epirubicin, vincristine)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 286
Study: 12052603

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol moistened with 1 mL of 3% acetic acid solution
Number of subjects: 177

Group type: COMPARATOR
Intervention: Intravaginal misoprostol in dry tablet form
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 177
Study: 10397281

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC+ subjects
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC- subjects
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in both OC+ and OC- subjects
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg) in OC+ subjects during midcycle
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Alcohol (0.34-1.02 g/kg) in OC+ subjects (substudy)
Number of subjects: 61
Study: 8800888

Group type: EXPERIMENTAL
Intervention: Side‐fire laser prostatectomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Side‐fire laser with debridement
Number of subjects: 40

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups after 1 year
Number of subjects: 40
Study: 2004941

Group type: EXPERIMENTAL
Intervention: Delayed split whole abdominal irradiation (DSA)
Number of subjects: 58
Study: 6577774

Group type: EXPERIMENTAL
Intervention: High volume water intake (excess volume)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Low volume water intake (average estimated requirement)
Number of subjects: 190
Study: 29627620

Group type: EXPERIMENTAL
Intervention: LUB 12 μg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: LUB 24 μg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 25252727

Group type: EXPERIMENTAL
Intervention: 500 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1000 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2000 mg of cefetamet sodium for IV infusion over 30 minutes
Number of subjects: 12
Study: 25571864

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) exercise education intervention (Group A)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: First education intervention (Group B)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 145
Study: 23949430

Group type: EXPERIMENTAL
Intervention: Dinaciclib 50 mg/m² given as a 2-h infusion every 21 days
Number of subjects: 20
Study: 20886398

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 127
Study: 18563333

Group type: EXPERIMENTAL
Intervention: Short-segment pedicle screw fixation with posterior morselized bone grafting (Group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Short-segment pedicle screw fixation without morselized bone grafting (Group B)
Number of subjects: 70
Study: 15858936

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (3 microg/kg) added to the cardioplegic solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (3 microg/kg) added to the cardioplegic solution
Number of subjects: 30
Study: 14503094

Group type: EXPERIMENTAL
Intervention: Telithromycin for 5 days
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Telithromycin for 10 days
Number of subjects: 754

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid for 10 days
Number of subjects: 754
Study: 10374221

Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy (0.625 mg esterified estrogens combined with 1.25 mg methyltestosterone)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy (1.25 mg esterified estrogens combined with 2.5 mg methyltestosterone)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Estrogen-only therapy (0.625 mg esterified estrogens)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Estrogen-only therapy (1.25 mg esterified estrogens)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Estrogen-androgen therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: Estrogen treatment
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Estrogen-androgen treatment
Number of subjects: 93
Study: 8679349

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 64

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 64
Study: 1905372

Group type: EXPERIMENTAL
Intervention: Doxycycline (45 days) plus Rifampin (21 days)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Doxycycline (45 days) plus Streptomycin (14 days)
Number of subjects: 84
Study: 6345023

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery (group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drug therapy (group 2)
Number of subjects: 100
Study: 30192210

Group type: EXPERIMENTAL
Intervention: Home-Based Cardiac Telerehabilitation (HBCTR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 80
Study: 29023310

Group type: EXPERIMENTAL
Intervention: Lid-Parallel Conjunctival Folds (LIPCOF)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Noninvasive break-up time (NIKBUT)
Number of subjects: 148
Study: 26086328

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Liberal sodium diet
Number of subjects: 20
Study: 23540718

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 262
Study: 21248633

Group type: EXPERIMENTAL
Intervention: Pylorus-resecting pancreatoduodenectomy (PrPD)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Pylorus-preserving pancreatoduodenectomy (PpPD)
Number of subjects: 130
Study: 18325516

Group type: EXPERIMENTAL
Intervention: Increasing doses of E(2) from days 3 to 5 (group 1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No hormonal treatment (group 2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Increasing doses of E(2) for 15 days (group 3)
Number of subjects: 21
Study: 17190528

Group type: EXPERIMENTAL
Intervention: Stimulant and nonstimulant medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-acting medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negotiated trial of time off treatment
Number of subjects: 0
Study: 15548275

Group type: EXPERIMENTAL
Intervention: Clearfil Core/New Bond (Kuraray)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Multilink (Vivadent)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Panavia 21/ED Primer (Kuraray)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PermaFlo DC (Ultradent)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Variolink II/Excite DSC (Vivadent)
Number of subjects: 50
Study: 11574353

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9752283

Group type: EXPERIMENTAL
Intervention: Granisetron (Gra) 1 mg
Number of subjects: 188

Group type: COMPARATOR
Intervention: Ondansetron (Ond) 8 mg
Number of subjects: 188
Study: 7583864

Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate 50 micrograms bid via Diskhaler
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 2195102

Group type: EXPERIMENTAL
Intervention: 0.125 mg of triazolam
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 0.25 mg of triazolam
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 748488

Group type: EXPERIMENTAL
Intervention: Fluocinolone cream applied twice a day for five days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inert carrier base applied twice a day for five days
Number of subjects: 0
Study: 31714801

Group type: EXPERIMENTAL
Intervention: Diagonally aligned sitting training on a tilted surface (10° backward and down toward the most affected side)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Diagonally aligned sitting training on a tilted surface
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (horizontal surface)
Number of subjects: 33
Study: 30266266

Group type: EXPERIMENTAL
Intervention: Provider Success narrative
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Provider Bias narrative
Number of subjects: 280

Group type: COMPARATOR
Intervention: Non-narrative Control
Number of subjects: 280
Study: 25869603

Group type: EXPERIMENTAL
Intervention: Overweight/obese children
Number of subjects: 185
Study: 22976445

Group type: EXPERIMENTAL
Intervention: Training program using the prosthesis simulator for 5 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 48
Study: 22470019

Group type: EXPERIMENTAL
Intervention: Ground-roasted peanuts without skin (GRPWS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Raw peanuts with skin (RPS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 13

Group type: COMPARATOR
Intervention: Roasted peanuts without skin
Number of subjects: 13
Study: 20716911

Group type: EXPERIMENTAL
Intervention: 20 g of creatine (Cr)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 18
Study: 16485230

Group type: EXPERIMENTAL
Intervention: Colour Doppler imaging (CDI) in normal pressure glaucoma patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 30
Study: 15231367

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (16 mg for 4 weeks tapered to 4 mg for 4 months)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 10646895

Group type: EXPERIMENTAL
Intervention: L-carnitine treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-carnitine treatment in tumour-bearing mice
Number of subjects: 0
Study: 8958001

Group type: EXPERIMENTAL
Intervention: Ethanol (0.66 g ethanol/kg orally followed by 0.1 g ethanol/kg per h intravenously)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (identical volumes of oral water and intravenous saline)
Number of subjects: 10
Study: 1579252

Group type: EXPERIMENTAL
Intervention: 30 MIU rt-PA
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 20 MIU rt-PA
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 4014185

Group type: EXPERIMENTAL
Intervention: Interviewer-administered questionnaire
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-administered questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical and cigarette smoking variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet histories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects and spouses
Number of subjects: 0
Study: 30366687

Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation platform and 8-week curriculum of independent practice of aortic and coronary anastomosis
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual operative experience (Control)
Number of subjects: 29
Study: 28776134

Group type: EXPERIMENTAL
Intervention: Superelastic shape‐memory alloy (SNT) rod
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional titanium alloy (CTA) rod
Number of subjects: 24
Study: 26948697

Group type: EXPERIMENTAL
Intervention: SPIRIT‐HF
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 29
Study: 23412948

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 4407
Study: 22231921

Group type: EXPERIMENTAL
Intervention: Vitamins B(1) + B(6) (n=6)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vitamin B(6) (n=11)
Number of subjects: 31
Study: 20061883

Group type: EXPERIMENTAL
Intervention: Multilevel intervention based on the ecological model, implemented over a 2-year period with worksite-wide events and employee-based advisory boards.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Comparison condition (control group)
Number of subjects: 34